nach oben

Erschienen in:

01.09.2013 | Original Article

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer

verfasst von: Jessica P. Gopie, Marc A. M. Mureau, Caroline Seynaeve, Moniek M. ter Kuile, Marian B. E. Menke-Pluymers, Reinier Timman, Aad Tibben

Erschienen in: Familial Cancer | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The outcome of bilateral prophylactic mastectomy with breast reconstruction (BPM-IBR) in healthy BRCA1/2 mutation carriers can be potentially burdensome for body image and the intimate relationship. Therefore, in the current analysis the impact on body image, sexual and partner relationship satisfaction was prospectively investigated in women opting for BPM-IBR as well as cancer distress and general quality of life. Healthy women undergoing BPM-IBR completed questionnaires preoperatively (T0, n = 48), at 6 months (T1, n = 44) and after finishing breast reconstruction (median 21 months, range 12–35) (T2, n = 36). With multi-level regression analyses the course of outcome variables was investigated and a statistically significant change in body image and/or sexual and partner relationship satisfaction was predicted by baseline covariates. Body image significantly decreased at T1. At T2 sexual relationship satisfaction and body image tended to be lower compared to baseline. The overall partner relationship satisfaction did not significantly change. At T2, 37 % of the women reported that their breasts felt unpleasantly, 29 % was not satisfied with their breast appearance and 21 % felt embarrassed for their naked body. Most body image issues remained unchanged in 30 % of the women. A negative body image was predicted by high preoperative cancer distress. BPM-IBR was associated with adverse impact on body image in a substantial subgroup, but satisfaction with the overall sexual and partner relationship did not significantly change in time. The psychosocial impact of BPM-IBR in unaffected women should not be underestimated. Psychological support should ideally be integrated both before and after BPM-IBR.

Leiden University Medical Center (LUMC), Erasmus University Medical Center Rotterdam (Erasmus MC), Daniel den Hoed Cancer Centre, Haga Teaching Hospital (Haga), Admiraal de Ruyter Hospital Goes.

Correlation coefficients with body image change scores were calculated for the following baseline psychological variables: sexual and partner relationship satisfaction, cancer distress and general mental and physical health.

Dropout reasons: questionnaires were “too general” or “time consuming”, having had complications, “there was no cancer distress as there was no cancer”, and “not feeling psychologically stable”.

Sexual and partner relationship satisfaction was only completed by women with a partner, therefore, N may be lower than 32 for these variables.

The four women without a BRCA1/2 mutation preferred PM over surveillance and after multidisciplinary consultation, they were allowed to have surgery.

King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643–646PubMedCrossRef

Ford D, Easton DF, Stratton M et al (1998) Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62(3):676–689PubMedCrossRef

Antoniou A, Pharoah PDP, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117–1130PubMedCrossRef

Hartmann LC, Sellers TA, Schaid DJ et al (2001) Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Nat Cancer Inst 93(21):1633–1637PubMedCrossRef

Hartmann LC, Schaid DJ, Woods JE et al (1999) Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340(2):77–84PubMedCrossRef

Rebbeck TR, Friebel T, Lynch HT et al (2004) Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. J Clin Oncol 22(6):1055–1062PubMedCrossRef

Evans DGR, Lalloo F, Ashcroft L et al (2009) Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev 18(8):2318–2324PubMedCrossRef

Metcalfe KA, Birenbaum-Carmeli D, Lubinski J et al (2008) International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers. Int J Cancer 122(9):2017–2022PubMedCrossRef

Brandberg Y, Sandelin K, Erikson S et al (2008) Psychological reactions, quality of life, and body image after bilateral prophylactic mastectomy in women at high risk for breast cancer: a prospective 1-year follow-up study. J Clin Oncol 26(24):3943–3949PubMedCrossRef

10.

Bresser PJC, Seynaeve C, Van Gool AR et al (2006) Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed women. Plast Reconstruct Surgery 117(6):1675–1682CrossRef

11.

den Heijer M, Seynaeve C, Timman R et al (2011) Body image and psychological distress after prophylactic mastectomy and breast reconstruction in genetically predisposed women: a prospective long-term follow-up study. Eur J Cancer 48(9):1263–1268CrossRef

12.

Frost MH, Schaid DJ, Sellers TA et al (2000) Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284(3):319–324PubMedCrossRef

13.

Gahm J, Wickman M, Brandberg Y (2010) Bilateral prophylactic mastectomy in women with inherited risk of breast cancer–prevalence of pain and discomfort, impact on sexuality, quality of life and feelings of regret two years after surgery. Breast 19(6):462–469PubMedCrossRef

14.

Hatcher MB, Fallowfield L, A’Hern R (2001) The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews. Br Med J 322(7278):76–79CrossRef

15.

Hopwood P, Lee A, Shenton A et al (2000) Clinical follow-up after bilateral risk reducing (‘prophylactic’) mastectomy: mental health and body image outcomes. Psycho-Oncology 9(6):462–472PubMedCrossRef

16.

Lodder LN, Frets PG, Trijsburg RW et al (2002) One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (Surveillance or prophylactic surgery). Breast Cancer Res Treat 73(2):97–112PubMedCrossRef

17.

McGaughey A (2006) Body image after bilateral prophylactic mastectomy: an integrative literature review. J Midwifery Women’s Health 51(6):e45–e49CrossRef

18.

van Oostrom I, Meijers-Heijboer H, Ladder LN et al (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21(20):3867–3874PubMedCrossRef

19.

Metcalfe KA, Esplen MJ, Goel V et al (2004) Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho-Oncology 13(1):14–25PubMedCrossRef

20.

Bresser P, Seynaeve C, Van Gool A et al (2007) The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. Eur J Cancer 43(1):95–103PubMedCrossRef

21.

Gopie JP, Timman R, Hilhorst MT et al (2011) Information-seeking behaviour and coping style of women opting for either implant or DIEP-flap breast reconstruction. J Plast Reconstruct Aesth Surgery 64(9):1167–1173CrossRef

22.

Gopie JP, Hilhorst MT, Kleijne A et al (2011) Women’s motives to opt for either implant or DIEP-flap breast reconstruction. J Plast Reconstruct Aesth Surgery 64(8):1062–1067CrossRef

23.

Gopie JP, Timman R, Hilhorst MT et al (2011) The short-term psychological impact of complications after breast reconstruction. Psycho-Oncology. doi:10.1002/pon.2089 PubMed

24.

Cull AM (1992) The assessment of sexual function in cancer-patients. Eur J Cancer 28A(10):1680–1686PubMedCrossRef

25.

Hopwood P (1993) The assessment of body-image in cancer-patients. Eur J Cancer 29A(2):276–281PubMedCrossRef

26.

Barelds DPH, Luteijn F, Arrindell WA (2003) NRV—Nederlandse Relatie Vragenlijst—Handleiding. Swets Test Publishers, Lisse

27.

Aaronson NK, Muller M, Cohen PDA et al (1998) Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51(11):1055–1068PubMedCrossRef

28.

Ware JE (2000) SF-36 health survey update. Spine 25(24):3130–3139PubMedCrossRef

29.

www.sf-36.org 2011

30.

van der Ploeg E, Mooren TTM, Kleber RJ et al (2004) Construct validation of the Dutch version of the impact of event scale. Psychol Assess 16(1):16–26PubMedCrossRef

31.

Horowitz M, Wilner N, Alvarez W (1979) Impact of event scale: measure of subjective stress. Psychosom Med 41(3):209–218PubMed

32.

Joseph S (2000) Psychometric evaluation of Horowitz’s impact of event scale: a review. J Traumatic Stress 13(1):101–113CrossRef

33.

Horowitz MJ (1982) Stress response syndromes and their treatment. In: Goldberger L, Breznitz S (eds) Handbook of stress. Theoretical and clinical aspects. The Free Press, New York, pp 711–732

34.

Cohen J (1988) Statistical power analysis for the behavioral sciences. Lawrence Erlbaum Associates, New Jersey

35.

Hox J (2002) Multilevel analysis: techniques and applications. Erlbaum, Mahwah

36.

Singer J, Willet J (2003) Applied longitudinal data analysis: modeling change and event occurrence. Oxford University Press, OxfordCrossRef

37.

Zion SM, Slezak JM, Sellers TA et al (2003) Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 98(10):2152–2160PubMedCrossRef

38.

Eldor L, Spiegel A (2009) Breast reconstruction after bilateral prophylactic mastectomy in women at high risk for breast cancer. Breast J 15:S81–S89

39.

Barton MB, West CN, Liu IL et al (2005) Complications following bilateral prophylactic mastectomy. J Nat Cancer Inst Monogr 35:61–66CrossRef

40.

Heemskerk-Gerritsen BAM, Brekelmans CTM, Menke-Pluymers MBE et al (2007) Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam family cancer clinic. Ann Surg Oncol 14(12):3335–3344PubMedCrossRef

41.

Damen THC, Mureau MAM, Timman R et al (2009) The pleasing end result after DIEP flap breast reconstruction: a review of additional operations. J Plast Reconstruct Aesth Surg 62(1):71–76CrossRef

42.

Damen THC, Wei W, Mureau MAM et al (2011) Medium-term cost analysis of breast reconstructions in a single Dutch centre: a comparison of implants, implants preceeded by tissue expansion, LD transpositions and DIEP flaps. J Plast Reconstruct Aesth Surg 64(8):1043–1053CrossRef

43.

Kauff ND, Satagopan JM, Robson ME et al (2002) Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346(21):1609–1615PubMedCrossRef

44.

Finch A, Beiner M, Lubinski J et al (2006) Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation. JAMA 296(2):185–192PubMedCrossRef

45.

Benshushan A, Rojansky N, Chaviv M et al (2009) Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy. Climacteric 12(5):404–409PubMedCrossRef

46.

Madalinska JB, Hollenstein J, Bleiker E et al (2005) Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. J Clin Oncol 23(28):6890–6898PubMedCrossRef

47.

Finch A, Narod SA (2011) Quality of life and health status after prophylactic salpingo-oophorectomy in women who carry a BRCA mutation: a review. Maturitas 70(3):261–265PubMedCrossRef

48.

Pusic AL, Klassen AF, Scott AM et al (2009) Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstruct Surg 124(2):345–353CrossRef

49.

Arver B, Isaksson K, Atterhem H et al (2011) Bilateral prophylactic mastectomy in Swedish women at high risk of breast cancer: a national survey. Ann Surg 253(6):1147–1154PubMedCrossRef

50.

Kaas R, Verhoef S, Wesseling J et al (2010) Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers very low risk for subsequent breast cancer. Ann Surg 251(3):488–492PubMedCrossRef

51.

Brandberg Y, Malm M, Rutqvist LE et al (1999) A prospective randomised study (named SVEA) of three methods of delayed breast reconstruction. Study design, patients’ preoperative problems and expectations. Scand J Plast Reconstruct Surg Hand Surg 33(2):209–216CrossRef

52.

Contant CME, van Wersch AMEA, Wiggers T et al (2000) Motivations, satisfaction, and information of immediate breast reconstruction following mastectomy. Patient Educ Couns 40(3):201–208PubMedCrossRef

53.

Fuller S, Anderson RC (2009) Adjustment issues related to bilateral prophylactic mastectomy in women at elevated risk of developing breast cancer. Plast Surg Nurs Off J Am Soc Plast Reconstruct Surg Nurs 29(1):33–38

54.

Snell L, McCarthy C, Klassen A et al (2010) Clarifying the expectations of patients undergoing implant breast reconstruction: a qualitative study. Plast Reconstruct Surg 126(6):1825–1830CrossRef

55.

Tan MBM, Bleiker EMA, Menke-Pluymers MBE, et al (2009) Standard psychological consultations and follow up for women at increased risk of hereditary breast cancer considering prophylactic mastectomy. Hered Cancer Clin Pract 7

Titel: Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer
verfasst von: Jessica P. Gopie
Marc A. M. Mureau
Caroline Seynaeve
Moniek M. ter Kuile
Marian B. E. Menke-Pluymers
Reinier Timman
Aad Tibben
Publikationsdatum: 01.09.2013
Verlag: Springer Netherlands
Erschienen in: Familial Cancer / Ausgabe 3/2013
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-012-9588-5

Neu im Fachgebiet Onkologie

25.04.2024 | Nierenkarzinom | Nachrichten

Springer Medizin

Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer

Abstract

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Cancer family history triage: a key step in the decision to offer screening and genetic testing

Detection of large deletions in the VHL gene using a Real-Time PCR with SYBR Green

Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India

Mutation screening in a Norwegian cohort with pheochromocytoma

The risk of gastric cancer in carriers of CHEK2 mutations

Diagnosis and management of BHD-associated kidney cancer

Neu im Fachgebiet Onkologie

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Bei Senioren mit Prostatakarzinom auf Anämie achten!

ICI-Therapie in der Schwangerschaft wird gut toleriert

Update Onkologie